Analysis of One Patient with Infection by Carbapenem-resistant Escherichia Coli / 中国药师
China Pharmacist
;
(12): 889-892, 2018.
Article
in Chinese
| WPRIM
| ID: wpr-705619
ABSTRACT
To evaluate the medication for one patient with the infection by carbapenem-resistant escherichia coli (CRE) to provide reference for the treatment of drug-resistance bacteria in clinical practice. During the development of anti-infective treatment regimen, clinical pharmacists analyzed and evaluated the situation, and provided suggestions for the medicationamikacin combined with fosfomycin and tigecycline. Physician adopted the recommendations,and the infective symptoms obtained a better control. The participation of clinical pharmacists in the treatment of intractable infection practice can provide reasonable and effective medication recommendations for clinics to improve anti-infective effectiveness in clinics.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Practice guideline
Language:
Chinese
Journal:
China Pharmacist
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS